Notification of Interim Results

RNS Number : 8119O

Immupharma PLC

23 September 2011

 



For Immediate Release

23 September 2011

ImmuPharma PLC

Notification of Interim Results

Date: 30 September 2011

ImmuPharma PLC (AIM:IMM), the specialist discovery and development pharmaceutical company, is scheduled to announce its Interim Results for the six months ended  30 June 2011 on 30 September 2011.

-     Ends  -

For further information, please contact:

ImmuPharma PLC
Dr Robert Zimmer, President	[phone]
Richard Warr, Chairman	[phone]
Dimitri Dimitriou, Chief Executive Officer	[phone]
Buchanan Communications	+ 44 20 7466 5000
Lisa Baderoon, Mark Court
Panmure Gordon & Co	[phone]
Andrew Burnett
Espirito Santo Investment Bank	[phone]
James Bromhead, Richard Crawley

 

END

 

 

NORVXLBLFKFXBBL